In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study.

  • Annette Diener
  • Salomé Celemín-Heinrich
  • Karl Wegscheider
  • Kai Kolpatzik
  • Katrin Tomaschko
  • Attila Altiner
  • Norbert Donner-Banzhoff
  • Jörg Haasenritter

Abstract

Calculation of individual risk is the cornerstone of effective cardiovascular prevention. arriba is a software to estimate the individual risk to suffer a cardiovascular event in 10 years. Prognosis and the absolute effects of pharmacological and lifestyle interventions help the patient make a well-informed decision. The risk calculation algorithm currently used in arriba is based on the Framingham risk algorithm calibrated to the German setting. The objective of this study is to evaluate and adapt the algorithm for the target population in primary care in Germany.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1471-2296
DOIs
StatusVeröffentlicht - 2013
pubmed 23339773